Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord

Journal of Neurochemistry

Volumn 85, Issue 2, 2003, Pages 432-442

  Hu, J H ^a   Zhang, H ^c   Wagey, R ^b   Krieger, C ^a,b   Pelech, S L ^b,c  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Kinexus Bioinformatics   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Expression; Phosphoprotein; Phosphorylation; Protein kinase; Protein phosphatase

Indexed keywords

ADDUCIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE B; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C ZETA; PROTEIN P70; PROTEIN TYROSINE PHOSPHATASE; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; SPINAL CORD;

ANIMALIA;

EID: 0345184327     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01670.x     Document Type: Article

References (33)

1. Bajaj N. P., Al-Sarraj S. T., Anderson V., Kibble M., Leigh N. and Miller C. C. (1998) Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis. Neurosci. Lett. 245, 45-48.
2. Bajaj N. P., al-Sarraj S. T., Leigh P. N., Anderson V. and Miller C. C. (1999) Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog. Neuropsychopharmacol. Biol. Psychiatry 23, 833-850.
3. Battaini F. (2001) Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol. Res. 44, 353-361.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal. Biochem. 72, 248-254.
5. Cross D. A., Culbert A. A., Chalmers K. A., Facci L., Skaper S. D. and Reith A. D. (2001) Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. J. Neurochem. 77, 94-102.
6. Derick L. H., Liu S. C., Chishti A. H. and Palek J. (1992) Protein immunolocalization in the spread erythrocyte membrane skeleton. Eur. J. Cell. Biol. 57, 317-320.
7. Eisen A. and Krieger C. (1998) Amyotrophic Lateral Sclerosis: A Synthesis of Research and Clinical Practice. Cambridge University Press, Cambridge, UK.
8. Felipo V., Minana M. D. and Grisolia S. (1993) Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures. Brain. Res. 604, 192-196.
9. Ferrer I., Blanco R., Carmona M., Puig B., Barrachina M., Gomez C. and Ambrosio S. (2001) Active, phosphorylation-dependent mitogenactivated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. J. Neural. Transm. 108, 1383-1396.
10. Hu J. H., Chemoff K., Pelech S. and Krieger C. (2003) Protein kinase and protein phosphatase expression in the CNS of G93A mSOD over-expressing mice J. Neurochem. 85, 432-442.
11. ++dependent association with sites of cell - cell contact. J. Cell. Biol. 109, 557-569.
12. 2+ and protein kinase C. Trends Pharmacol. Sci. 17, 114-120.
13. Lanius R. A., Paddon H. B., Mezei M., Wagey R., Krieger C., Pelech S. L. and Shaw C. A. (1995) A role for amplified protein kinase C activity in the pathogenesis of amyotrophic lateral sclerosis. J. Neurochem. 65, 927-930.
14. Lanius R. A., Wagey R., Sahl B., Beattie B. L., Feldman H., Pelech S. L. and Krieger C. (1997) Protein kinase C activity and protein levels in Alzheimer's disease. Brain. Res. 764, 75-80.
15. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929-2938.
16. Matsuoka Y., Li X. and Bennett V. (1998) Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKSrelated domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons. J. Cell Biol. 142, 485-497.
17. McGeer P. L. and McGeer E. G. (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12, S1-S6.
18. Migheli A., Piva R. Atzori C., Troost D. and Schiffer D. (1997) c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 56, 1314-1322.
19. Morales M. and Fifkova E. (1989) In situ localization of myosin and actin in dendritic spines with the immunogold technique. J. Comp. Neurol. 279, 666-674.
20. Nagao M., Kato S., Oda M. and Hirai S. (1998) Decrease of protein kinase C in the spinal motor neurons of amyotrophic lateral sclerosis. Acta. Neuropathol. 96, 52-56.
21. Nakamura S., Kawamoto Y., Nakano S., Ikemoto A., Akiguchi I. and Kimura J. (1997) Cyclin-dependent kinase 5 in Lewy body-like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis. Neurology 48, 267-270.
22. Noh K. M., Hwang J. Y., Shin H. C. and Koh J. Y. (2000) A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol. Dis. 7, 375-383.
23. Pelech S., Sutter C. and Zhang H. (2002) Kinetworks™ protein kinase multiblot analysis. Methods in Molecular Biology: Cancer Cell Signaling: Methods and Protocols (Terrian D. M., ed.), Vol. 218, Humana Press, Totowa, NJ.
24. Seidel B., Zuschratter W., Wex H., Gamer C. C. and Gundelfinger E. D. (1995) Spatial and subcellular localization of the membrane cytoskeleton-associated protein alpha-adducin in the rat brain. Brain Res. 700, 13-24.
25. Shimamura A., Ballif B. A., Richards S. A. and Blenis J. (2000) Rskl mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 10, 127-135.
26. Smart T. G. (1997) Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr. Opin. Neurobiol. 7, 358-367.
27. Soderling T. R. (1999) The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 24, 232-236.
28. Somervaille T. C., Linch D. C. and Khwaja A. (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98, 1374-1381.
29. Taniguchi S., Fujita Y., Hayashi S., Kakita A., Takahashi H., Murayama S., Saido T. C., Hisanaga S., Iwatsubo T. and Hasegawa M. (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489, 46-50.
30. Wagey R., Pelech S. L., Duronio V. and Krieger C. (1998) Phosphatidylinositol 3-kinase: increased activity and protein level in amyotrophic lateral sclerosis. J. Neurochem. 71, 716-722.
31. Wagey R., Hu J., Pelech S. L., Raymond L. A. and Krieger C. (2001) Modulation of NMDA-mediated excitotoxicity by protein kinase C. J. Neurochem. 78, 715-726.
32. Xia Z., Dickens M., Raingeaud J., Davis R. J. and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
33. Zhang H., Shi X., Zhang Q. J., Hampong M., Paddon H., Wahyuningsih D. and Pelech S. (2002) Nocodazole-induced p53-dependent c-Jun N-terminal kinase activation reduces apoptosis in human colon carcinoma HCT-116 cells. J. Biol. Chem. 277, 43648-43658.